Gilead to build its EU CAR-T manufacturing facility at Amsterdam airport – FiercePharma
FiercePharma |
Gilead to build its EU CAR–T manufacturing facility at Amsterdam airport
FiercePharma Speed is of the essence when it comes to manufacturing CAR T drugs—personalized treatments in which immune cells are engineered to recognize and destroy patients' cancers. With that in mind, Gilead will locate a new European manufacturing site for its … Kite expands manufacturing capacity for CAR–T therapies |
